ASN
TRAW icon

Advisory Services Network’s Traws Pharma TRAW Stock Holding History

Advisory Services Network’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1
Closed -$2K – 2638
2018
Q2 		$2K Buy
+1
New +$2.9K ﹤0.01% 2300

Other funds holding TRAW

6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
TCP
Tyndall Capital Partners New York $452K AUM 26.52% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Advisory Services Network's TRAW Position: Q3 2018 in Review

Advisory Services Network sold out of Traws Pharma (TRAW) in Q3 2018, closing a stake of 1 share — an estimated $2K sold.

Advisory Services Network first reported a position in TRAW in Q2 2018 and held it in 1 quarter. The position peaked at $2K in Q2 2018. 13 funds tracked by Wall St. Rank hold TRAW as of Q3 2018.

  • Advisory Services Network reported no remaining Traws Pharma position as of Q3 2018 after selling out during the quarter.
  • Advisory Services Network sold 1 Traws Pharma share in Q3 2018, an estimated $2K.
  • Advisory Services Network first reported a position in Traws Pharma in Q2 2018 and held it in 1 quarter.
  • Advisory Services Network's Traws Pharma position peaked at $2K in Q2 2018.
  • 13 funds tracked by Wall St. Rank held Traws Pharma as of Q3 2018.

Based on Advisory Services Network's 13F filing for Q3 2018, filed 2 Nov 2018.